How to manage itching after a spinal procedure caused by intrathecal (in the spinal canal) opioids?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Itching After Spinal Anesthesia Due to Intrathecal Opioids

Start with antihistamines (diphenhydramine 25-50 mg IV/PO every 6 hours or promethazine 12.5-25 mg PO every 6 hours) as first-line treatment, and if this fails, escalate to low-dose nalbuphine (2.5-5 mg IV) or carefully titrated naloxone infusion (0.25 mcg/kg/h), as these are the most effective evidence-based interventions. 1, 2, 3

Understanding the Problem

Pruritus after intrathecal opioids is extremely common and predictable:

  • Intrathecal/epidural opioids cause pruritus in 20-100% of patients, making this the highest-risk route of administration 4, 1, 2
  • Intravenous opioids cause pruritus in only 10-50% of patients 4, 1
  • The itching typically occurs early in the course of opioid treatment 1, 2
  • While not life-threatening, it significantly decreases patient satisfaction and comfort 5

Stepwise Treatment Algorithm

First-Line: Antihistamines

  • Diphenhydramine 25-50 mg IV or PO every 6 hours (sedating option) 1, 2
  • Promethazine 12.5-25 mg PO every 6 hours (sedating option) 1, 2
  • Cetirizine may be used as a non-sedating alternative 1
  • Important caveat: Sedating antihistamines will compound opioid-induced sedation, requiring close monitoring 1, 2

Second-Line: Mixed Agonist-Antagonist

  • Nalbuphine 2.5-5 mg IV (25-50% of the analgesic dose) is superior to placebo, diphenhydramine, naloxone, and propofol for treating opioid-induced pruritus 3, 6
  • Nalbuphine provides pruritus relief without attenuating analgesia or increasing sedation when used at these lower doses 3
  • Can be dosed as 0.5-1 mg IV every 6 hours as needed 1
  • This is the most effective single agent based on systematic review evidence 3, 6

Third-Line: Opioid Antagonists

  • Naloxone continuous infusion starting at 0.25 mcg/kg/h, titrated carefully 1, 2
  • Naltrexone 6-9 mg is effective but may reduce duration of analgesia 4, 6
  • Naltrexone 3 mg is ineffective; 6 mg and 9 mg doses work but with analgesic trade-offs 4, 6
  • Critical warning: Careful dose titration is essential to avoid reversing analgesic effects 1, 2, 7
  • Methylnaltrexone (peripheral antagonist with reduced CNS penetration) may be considered as an alternative 4, 1

Fourth-Line: Alternative Agents

  • Droperidol 2.5 mg IV is efficacious for prophylaxis (not epidural route) 6
  • Ondansetron 4-8 mg may reduce severity but does not reduce incidence or time to onset 4, 7, 6
  • Mirtazapine or gabapentin as alternative antipruritic agents 1

What Does NOT Work

Avoid these ineffective interventions:

  • Ondansetron and other 5-HT3 antagonists do not reduce incidence of opioid-induced pruritus despite efficacy for nausea 4, 7
  • Prophylactic propofol (though low-dose propofol for established pruritus was studied, it showed no benefit) 6
  • Epidural clonidine, epidural prednisone, intramuscular hydroxyzine 6

Clinical Considerations for Intrathecal Morphine Use

When intrathecal morphine 0.1 mg is used for postoperative analgesia:

  • Pruritus occurs more frequently with the 0.1 mg dose compared to 0.05 mg, though pain relief is superior 4
  • The PROSPECT guidelines note significant controversy about using intrathecal morphine due to pruritus and nausea potentially delaying ambulation 4
  • Before attributing pruritus solely to opioids, assess for other causes including other medications and underlying conditions 1, 7

Common Pitfalls to Avoid

  • Do not use full doses of opioid antagonists in opioid-dependent patients as this precipitates withdrawal 7
  • Do not rely on ondansetron as first-line despite its efficacy for opioid-induced nausea 7
  • Do not overlook the compounding sedation when combining sedating antihistamines with neuraxial opioids 1, 2
  • Do not assume all antihistamines are equally effective—evidence specifically supports diphenhydramine and promethazine 1, 2

Prophylaxis Considerations

For prophylaxis in patients receiving neuraxial opioids:

  • Naloxone 0.25-2.4 mcg/kg/h IV has a number-needed-to-treat of 3.5 6
  • Nalbuphine (various regimens) has a number-needed-to-treat of 4.2 6
  • Droperidol 2.5 mg IV has a number-needed-to-treat of 4.9 6
  • Baseline incidence of pruritus with neuraxial opioids averages 59% (range 10-100%) 6

References

Guideline

Management of Opioid-Induced Pruritus

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Fentanyl-Induced Pruritus

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Ondansetron for Opioid-Induced Pruritus

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.